Monte Rosa Therapeutics GLUE
Last Price
52 Week Range
$3.50 - $19.17
Next Earnings Date
Mar 19 2026 (Estimate)
Next Earnings Date
Mar 19 2026 (Est.)
Last Price
GLUE Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Monte Rosa Therapeutics, Inc. | 8-K | December 16, 2025 | |
Monte Rosa Therapeutics, Inc. | 8-K | November 6, 2025 | |
Monte Rosa Therapeutics, Inc. | 10-Q | November 6, 2025 | |
Monte Rosa Therapeutics, Inc. | 8-K | September 15, 2025 | |
Monte Rosa Therapeutics, Inc. | 10-Q | August 7, 2025 | |
Monte Rosa Therapeutics, Inc. | 8-K | August 7, 2025 | |
Monte Rosa Therapeutics, Inc. | 8-K | June 13, 2025 | |
Monte Rosa Therapeutics, Inc. | 10-Q | May 8, 2025 | |
Monte Rosa Therapeutics, Inc. | 8-K | May 8, 2025 | |
Monte Rosa Therapeutics, Inc. | ARS | April 25, 2025 | |
Monte Rosa Therapeutics, Inc. | DEF 14A | April 25, 2025 | |
Monte Rosa Therapeutics, Inc. | DEFA14A | April 25, 2025 | |
Monte Rosa Therapeutics, Inc. | 8-K | March 20, 2025 | |
Monte Rosa Therapeutics, Inc. | 10-K | March 20, 2025 | |
Monte Rosa Therapeutics, Inc. | 8-K | January 10, 2025 | |
Monte Rosa Therapeutics, Inc. | 8-K | December 13, 2024 | |
Monte Rosa Therapeutics, Inc. | 8-K | December 5, 2024 | |
Monte Rosa Therapeutics, Inc. | 10-Q | November 7, 2024 | |
Monte Rosa Therapeutics, Inc. | 8-K | November 7, 2024 | |
Monte Rosa Therapeutics, Inc. | 8-K | October 28, 2024 | |
Monte Rosa Therapeutics, Inc. | 8-K | August 8, 2024 | |
Monte Rosa Therapeutics, Inc. | 10-Q | August 8, 2024 | |
Monte Rosa Therapeutics, Inc. | 8-K | June 27, 2024 | |
Monte Rosa Therapeutics, Inc. | 8-K | June 12, 2024 | |
Monte Rosa Therapeutics, Inc. | 8-K | May 30, 2024 | |
Monte Rosa Therapeutics, Inc. | 8-K | May 16, 2024 | |
Monte Rosa Therapeutics, Inc. | 10-Q | May 9, 2024 | |
Monte Rosa Therapeutics, Inc. | 8-K | May 9, 2024 | |
Monte Rosa Therapeutics, Inc. | 8-K | May 2, 2024 | |
Monte Rosa Therapeutics, Inc. | DEFA14A | April 26, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.